What’s New in Osteoporosis and Fragility Fractures 2022
The recent JBJS Guest Editorial “What’s New in Osteoporosis and Fragility Fractures” provides an update on this important …
Halt Bisphosphonates in Patients with an Atypical Femoral Fracture
Osteoporosis is the major contributor to the increasing incidence of fragility fractures associated with low-energy falls. The other contributor is …
Atypical Femoral Fractures: Predicting Post-surgical Healing Problems
Orthopaedic journals and OrthoBuzz have devoted ample space to the apparent association between long-term bisphosphonate use and atypical femoral fractures. …
BMJ Studies Address Safety of Devices and Alendronate
BMJ recently published two studies of interest to orthopaedists:
- After analyzing data from more than 200 cardiovascular, orthopaedic, and neurologic